Associations

Intranasal ketamine for chronic migraine

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: Research Subanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an alternative option for outpatient care. Methods A retrospective study was conducted at a single tertiary headache center to assess the clinical […]

Intranasal ketamine for chronic migraine Read More »

EMHA and Prof. Peter Goadsby at BBVA.

At EMHA, we believe that the health and wellbeing of employees is paramount to their success in the workplace. That’s why we were proud to co-host a conference with BBVA that centered on health and emotional management. Our esteemed guest, Professor Peter Goadsby from King’s College London, provided valuable insights on migraines and how to

EMHA and Prof. Peter Goadsby at BBVA. Read More »

Suggestions for headache care at coronavirus time

Suggestions for headache care at coronavirus time by  The European Headache Federation (EHF) and The European Migraine & Headache Alliance (EMHA) Coronavirus pandemia has completely changed health systems’ organization and priorities. Headache service are heavily affected by those changes. They have been suspended or reduced, to limit social contacts. Patients also would rather stay at home.

Suggestions for headache care at coronavirus time Read More »

Migraine Association of Ireland

Migraine Awareness Week 2018 MAI held an accredited Health Care Professional Seminar, during which two international speakers presented on Migraine: Diagnosis and Treatment, and the Development of the new Anti-CGRP medication. Prof. Lars Edvinsson and Prof. Allan Purdy, both members of the IHS, followed this up by doing a webinar for members of the Irish

Migraine Association of Ireland Read More »

How to access innovative treatments by FindMeCure Foundation

FindMeCure Widget  Medical science has been rapidly advancing in the recent decades and we can prove that with many examples: new therapies for diabetes, the first vaccine for the prevention of cervical cancer, oral treatments for Hepatitis C curing more than 90% of the cases, the first Lupus drug in 50 years, personalized medicines to

How to access innovative treatments by FindMeCure Foundation Read More »

Move For Migraine

Move For Migraine Migraine remains an overlooked and misunderstood condition in many parts of Europe, including Belgium. The disease suffers from a lack of recognition and understanding, even from the first concerned parties (patients, caregivers, employers, etc.). This comes at a significant burden for the patients and at a high cost for society (1,650,000 working

Move For Migraine Read More »

EPF publishes a guide for patient organisations on the new Data Protection Regulation

The new Regulation on personal data protection (EU/2016/679) was published in May 2016 and will apply from May 2018. It provides more rights to citizens to be better informed about the use made of their personal data, and gives clearer responsibilities to people and entities using personal data. Patients’ fundamental right to protection of their health data

EPF publishes a guide for patient organisations on the new Data Protection Regulation Read More »

European Patients’ Rights Day, TODAY, April 18

Patients claim their right to participate in Decision about their Health Patients have the right to participate in making decisions about their health, either through patient organizations in public policies that affect them or through the sharing of information and consensus with their doctor, for example, about what treatment to follow. This is one of

European Patients’ Rights Day, TODAY, April 18 Read More »

Scroll to Top
Search
Close this search box.